Dalbavancin, Vancomycin and Daptomycin Alone and in Combination with Cefazolin against Resistant Phenotypes of <i>Staphylococcus aureus</i> in a Pharmacokinetic/Pharmacodynamic Model

Dalbavancin, Vancomycin and Daptomycin Alone and in Combination with Cefazolin against Resistant Phenotypes of <i>Staphylococcus aureus</i> in a Pharmacokinetic/Pharmacodynamic Model

The most efficacious antimicrobial therapy to aid in the successful elimination of resistant <i>S. aureus</i> infections is unknown. In this study, we evaluated varying phenotypes of <i>S. aureus</i> against dalbavancin (DAL), vancomycin (VAN), and daptomycin (DAP) alone and...

Full description

Bibliographic Details
Main Authors: Jacinda C. Abdul-Mutakabbir, Razieh Kebriaei, Kyle C. Stamper, Zain Sheikh, Philip T. Maassen, Katherine L. Lev, Michael J. Rybak
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Antibiotics
Subjects:
<i>Staphylococcus aureus</i>
antimicrobial resistance
pharmacokinetics
pharmacodynamics
Online Access:https://www.mdpi.com/2079-6382/9/10/696

Similar Items

Similar Items